浜田 将太






2005年 広島大学 医学部 総合薬学科 卒業(薬剤師免許)
2007年 広島大学 大学院医歯薬学総合研究科 薬学専攻 博士課程前期 修了
2010年 京都大学 大学院医学研究科 社会健康医学系専攻 専門職学位課程 修了
2013年 京都大学 大学院医学研究科 社会健康医学系専攻 博士後期課程 研究指導認定退学
2014年 博士(社会健康医学)


2007年 製薬企業 研究開発・薬事職(~2013年)
2013年 京都大学 大学院医学研究科 薬剤疫学分野 特定助教(~2014年)
2014年 キングス・カレッジ・ロンドン 生命科学・医学部 客員研究員(~2018年)
2016年 医療経済研究機構 研究員(~2018年)
2018年 同 主任研究員(~2019年)
2019年 同 主席研究員

筑波大学医学医療系ヘルスサービスリサーチ分野 客員准教授
東京大学大学院医学系研究科 在宅医療学講座 特任助教




Ⅰ. 筆頭/責任(抜粋)

  • 1.Hamada S, Kojima T, Sakata N, et al. Changes in use of high-priced new drugs and drug costs among residents of long-term care facilities under a bundled payment system: Case studies of dipeptidyl peptidase-4 inhibitors and direct oral anticoagulants. Geriatr Gerontol Int. 2020;20(9):842-844.
  • 2.Hamada S, Kojima T, Maruoka H, et al. Utilization of drugs for the management of cardiovascular diseases at intermediate care facilities for older adults in Japan. Arch Gerontol Geriatr. 2020;88:104016.
  • 3.Hamada S, Kojima T, Sakata N, et al. Drug costs in long-term care facilities under a per diem bundled payment scheme in Japan. Geriatr Gerontol Int. 2019;19(7):667-672.
  • 4.Hamada S, Ohno Y, Kojima T, Ishii S, Okochi J, Akishita M. Prevalence of cytochrome P450-mediated potential drug-drug interactions in residents of intermediate care facilities for older adults in Japan. Geriatr Gerontol Int. 2019;19(6):513-517.
  • 5.Hamada S, Takahashi H, Sakata N, et al. Household income relationship with health services utilization and healthcare expenditures in people aged 75 years or older in Japan: A population-based study using medical and long-term care insurance claims data. J Epidemiol. 2019;29(10):377-383.
  • 6.Hamada S, Gulliford MC. Multiple risk factor control, mortality and cardiovascular events in type 2 diabetes and chronic kidney disease: a population-based cohort study. BMJ Open. 2018;8(5):e019950.
  • 7.Hamada S, Gulliford MC. Drug prescribing during the last year of life in very old people with diabetes. Age Ageing 2017;46(1):147-151.
  • 8.Hamada S, Gulliford MC. Mortality in Individuals Aged 80 and Older with Type 2 Diabetes Mellitus in Relation to Glycosylated Hemoglobin, Blood Pressure, and Total Cholesterol. J Am Geriatr Soc. 2016;64(7):1425-1431.
  • 9.Hamada S, Gulliford MC. Antidiabetic and cardiovascular drug utilisation in patients diagnosed with type 2 diabetes mellitus over the age of 80 years: a population-based cohort study. Age Ageing. 2015;44(4):566-573.
  • 10.Hamada S, Hinotsu S, Kawai K, et al. Antiemetic efficacy and safety of a combination of palonosetron, aprepitant, and dexamethasone in patients with testicular germ cell tumor receiving 5-day cisplatin-based combination chemotherapy. Support Care Cancer. 2014;22(8):2161-2166.
  • 11.Hamada S, Hinotsu S, Hori K, et al. The cost of antiemetic therapy for chemotherapy-induced nausea and vomiting in patients receiving platinum-containing regimens in daily practice in Japan: a retrospective study. Support Care Cancer. 2012;20(4):813-820.

Ⅱ. 共著(抜粋)

  • 1.Tsuchiya-Ito R, Ishizaki T, Mitsutake S, Hamada S, Yoshie S, Iijima K, Tamiya N. Association of household income with home-based rehabilitation and home help service utilization among long-term home care service users. BMC Geriatr. 2020;20(1):314.
  • 2.Hattori Y, Abe T, Kojima T, Hamada S, Ogawa S, Ura N, Akishita M. Potential prescribing omissions may have no influence on cause of death in care-dependent older adults with percutaneous endoscopic gastrostomy tube. Geriatr Gerontol Int. [Online ahead of print]
  • 3.Suzuki T, Iwagami M, Hamada S, Matsuda T, Tamiya N. Number of consulting medical institutions and risk of polypharmacy in community-dwelling older people under a healthcare system with free access: a cross-sectional study in Japan. BMC Health Serv Res. 2020;20(1):359.
  • 4.Ishizaki T, Mitsutake S, Hamada S, Teramoto C, Shimizu S, Akishita M, Ito H. Drug prescription patterns and factors associated with polypharmacy in >1 million older adults in Tokyo. Geriatr Gerontol Int. 2020;20(4):304-311.
  • 5.Adomi M, Iwagami M, Kawahara T, Hamada S, Iijima K, Yoshie S, Ishizaki T, Tamiya N. Factors associated with long-term urinary catheterisation and its impact on urinary tract infection among older people in the community: a population-based observational study in a city in Japan. BMJ Open. 2019;9(6):e028371.
  • 6.Mori T, Hamada S, Yoshie S, et al. The associations of multimorbidity with the sum of annual medical and long-term care expenditures in Japan. BMC Geriatr. 2019;19:16.
  • 7.Kuroda N, Hamada S, Sakata N, et al. Antipsychotic use and related factors among people with dementia aged 75 years or older in Japan: a comprehensive population-based estimation using medical and long-term care data. Int J Geriatr Psychiatry. 2019;34(3):472-479.
  • 8.Charlton J, Ravindrarajah R, Hamada S, Jackson SH, Gulliford MC. Trajectory of Total Cholesterol in The Last Years of Life Over Age 80 Years. Cohort Study of 99,758 Participants . J Gerontol A Biol Sci Med Sci. 2018;73(8):1083-1089.
  • 9.Gulliford M, Ravindrarajah R, Hamada S, Jackson S, Charlton J. Inception and deprescribing of statins in people aged over 80 years: cohort study. Age Ageing. 2017;46(6):1001-1005.
  • 10.Ravindrarajah R, Hazra NC, Hamada S, et al. Systolic blood pressure trajectory, frailty and all-cause mortality over 80 years of age. Cohort study using electronic health records. Circulation. 2017;135(24):2357-2368.
  • 11.Ravindrarajah R, Dregan A, Hazra NC, Hamada S, Jackson SHD, Gulliford MC. Declining blood pressure and intensification of blood pressure management among people over 80 years: cohort study using electronic health records. J Hypertens. 2017;35(6):1276-1282.
  • 12.Dregan A, Ravindrarajah R, Hazra N, Hamada S, Jackson SH, Gulliford MC. Longitudinal Trends in Hypertension Management and Mortality Among Octogenarians: Prospective Cohort Study. Hypertension. 2016;68(1):97-105.

Ⅰ. ガイドライン・指針

  • 1.高齢者の医薬品適正使用の指針(各論編(療養環境別)).令和元年6月14日.
  • 2.高齢者の医薬品適正使用の指針(総論編).平成30年5月29日.

Ⅱ. 報告書

  • 1.全国老人保健施設協会.介護老人保健施設のデータ収集システムの活用に関する調査研究事業報告書.令和2年3月.
  • 2.全国老人保健施設協会.介護老人保健施設における薬剤調整のあり方とかかりつけ医等との連携に関する調査研究事業報告書.平成29年3月.



Research Fields

Pharmacoepidemiology and Clinical epidemiology


Sep 2014 DrPH, Kyoto University (Public Health)
Mar 2010 MPH, Kyoto University (Public Health)
Mar 2007 MSc, Hiroshima University (Pharmaceutical sciences)
Mar 2005 BSc, Hiroshima University (Pharmaceutical sciences)

Academic & Professional Experience

Apr 2019 - Principal Researcher, Institute for Health Economics and Policy
Apr 2018 - Mar 2019 Senior Researcher, Institute for Health Economics and Policy
Apr 2016 - Mar 2018 Researcher, Institute for Health Economics and Policy
Apr 2014 - Mar 2018 Visiting Research Fellow, King's College London
Apr 2013 - Mar 2014 Program-Specific Assistant Professor, Kyoto University
Apr 2007 - Mar 2013 R&D and Regulatory Affairs, Pharmaceutical companies